AU5723001A - Ultrashort acting hypnotic barbiturates - Google Patents

Ultrashort acting hypnotic barbiturates

Info

Publication number
AU5723001A
AU5723001A AU5723001A AU5723001A AU5723001A AU 5723001 A AU5723001 A AU 5723001A AU 5723001 A AU5723001 A AU 5723001A AU 5723001 A AU5723001 A AU 5723001A AU 5723001 A AU5723001 A AU 5723001A
Authority
AU
Australia
Prior art keywords
acting hypnotic
ultrashort acting
barbiturates
hypnotic barbiturates
ultrashort
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5723001A
Other languages
English (en)
Inventor
Pascal Druzgala
Peter G Milner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARYx Therapeutics Inc
Original Assignee
ARYx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARYx Therapeutics Inc filed Critical ARYx Therapeutics Inc
Publication of AU5723001A publication Critical patent/AU5723001A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU5723001A 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates Pending AU5723001A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19914400P 2000-04-24 2000-04-24
PCT/US2001/013246 WO2001081319A2 (en) 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates

Publications (1)

Publication Number Publication Date
AU5723001A true AU5723001A (en) 2001-11-07

Family

ID=22736404

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5723001A Pending AU5723001A (en) 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates
AU2001257230A Ceased AU2001257230B2 (en) 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001257230A Ceased AU2001257230B2 (en) 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates

Country Status (6)

Country Link
US (4) US6387914B2 (enExample)
EP (1) EP1276728A2 (enExample)
JP (1) JP2003531196A (enExample)
AU (2) AU5723001A (enExample)
CA (1) CA2404898A1 (enExample)
WO (1) WO2001081319A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1276728A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics Ultrashort acting hypnotic barbiturates
US7049326B2 (en) * 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US6750238B1 (en) * 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US10537061B2 (en) * 2010-02-26 2020-01-21 Cnh Industrial America Llc System and method for controlling harvest operations
WO2014014960A1 (en) * 2012-07-16 2014-01-23 Dignity Health Treating of epilepsy and alcohol addiction with creatine
CA2961410C (en) 2014-09-16 2023-07-11 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
EP3247359A4 (en) 2015-01-25 2018-08-08 India Globalization Capital, Inc. Composition and method for treating seizure disorders
US10596159B2 (en) 2015-08-12 2020-03-24 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
EP3471746A4 (en) 2016-06-15 2020-02-26 India Globalization Capital, Inc. METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CS176667B1 (enExample) * 1975-02-17 1977-06-30
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them
DE69032871T2 (de) * 1989-11-14 1999-09-09 Sloan-Kettering Institute For Cancer Research Neue potente induktoren terminaler differenzierung und verfahren zu ihrer verwendung
CH678394A5 (enExample) * 1990-08-22 1991-09-13 Cerny Erich H
US5414085A (en) * 1992-04-06 1995-05-09 Biosite Diagnostics, Inc. Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
JPH06214344A (ja) * 1992-10-22 1994-08-05 Konica Corp ハロゲン化銀写真感光材料
JPH07120865A (ja) * 1993-10-21 1995-05-12 Konica Corp ハロゲン化銀写真感光材料
US6335332B1 (en) * 1997-06-21 2002-01-01 Roche Diagnostics Gmbh Barbituric acid derivatives with antimetastatic and antitumor activity
EP1276728A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics Ultrashort acting hypnotic barbiturates

Also Published As

Publication number Publication date
JP2003531196A (ja) 2003-10-21
USRE41289E1 (en) 2010-04-27
WO2001081319A2 (en) 2001-11-01
US20030100575A1 (en) 2003-05-29
US6387914B2 (en) 2002-05-14
US7041673B2 (en) 2006-05-09
US6683086B2 (en) 2004-01-27
AU2001257230B2 (en) 2006-09-14
WO2001081319A3 (en) 2002-05-16
CA2404898A1 (en) 2001-11-01
US20040167143A1 (en) 2004-08-26
EP1276728A2 (en) 2003-01-22
US20020013330A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU6931701A (en) Pyrimidine derivatives
AU3576801A (en) Pyrimidine compounds
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
IL136080A0 (en) Sequence-to-sequence alignment
TW483324U (en) Diaper
SG101520A1 (en) Disposable undergarment
IL141034A0 (en) Uracil compounds and use thereof
SG86470A1 (en) Disposable undergarment
TW489642U (en) Underpants-type diaper
IL185461A0 (en) Pyrimidine compounds and their use
TW477220U (en) Underpants-type diaper
AU9352801A (en) Diaper
DE50105770D1 (en) Di(het)arylaminothiophen-derivate
HRP20030362A2 (en) Pyrimidine derivatives
AU5723001A (en) Ultrashort acting hypnotic barbiturates
TW502582U (en) Transversely-opening-type underpants
GB2365376B (en) Broaching
SG87212A1 (en) Disposable undergarment
IL146531A0 (en) 5-substituted arylpyrimidines
GB0028423D0 (en) Eductional aid
GB0028494D0 (en) Tassel-making aid
GB0016696D0 (en) Urine aborber
TW443469U (en) Incinerator
SI1303496T1 (sl) Pirimidinski derivati
GB2385635B (en) Releasable restrictor